LIVE PLENARY SESSIONS
| (Israel Time) | MAY 11 |
| 4:00 pm – 4:15 pm | Welcome by Conference Chairpersons Ruti Alon, Ora Dar, Nissim Darvish |
| 4:15 pm – 4:55 pm | Francois Maisonrouge, Senior Managing Director in Evercore’s Advisory business “Fifteen Months into the Pandemic; Four Months into the Biden Administration What Have we Learned? What can we Expect? What Should we do?”
|
| 4:55 pm – 5:35 pm | Liz Barrett, President and Chief Executive Officer, UroGen Pharma “Multi Factorial Approaches to Treating Oncological Diseases”
|
| 5:35 pm – 6:15 pm | Prof. Ronni Gamzu, M.D., Ph.D., Chief Executive Officer, Tel Aviv Sourasky Medical Center Post Covid Techceleration |
(Israel Time) | MAY 12 |
4:00 pm – 4:40 pm | Barry Greene, Chief Executive Officer and Member of Board of Directors, Sage Therapeutics “Is There More to Discover in the Brain than on the Moon?” |
4:40 pm – 5:20 pm | Dr. John Halamka, President of Mayo Clinic Platform, Mayo Clinic “The Digital Reconstruction of Healthcare
|
5:20 pm – 6:00 pm | Dr. Jeremy Levin, Chairman and Chief Executive Officer, Ovid Therapeutics Inc. “Politics, Science, and Medicine do not Mix” |
(Israel Time) | MAY 13 |
4:00 pm–4:40 pm | Robert C. Cohen, President, Digital, Robotics, and Enabling Technologies, Stryker Corp. “Technology Benefiting Orthopedic Device Innovation” |
4:40 pm – 5:00 pm | Anya Eldan, Vice President, Israel Innovation Authority and Head of Startup Division Prof. Rivka Carmi, M.D., ex. President of Ben Gurion University, Chairwoman of Telem National Committee of Bio Conversion “BioConvergence – Building Medicine of the Future”
|
5:00 pm – 5:20 pm | Dr. Orna Berry, Entrepreneur, Scientist and Industry Executive The AI and Data Science National Committee Initiatives for Health and Medical Fields |
BIOMED PARTNERS TRACK
8400 FHIR VIDEO MOVIE (Hebrew only) |
8400 LIHI MANSANO (Hebrew Only) |
8400 MENTORING (Hebrew Only) |
8400 SPEARHEALTH (Hebrew Only) |
Cleveland Clinic |
Cleveland Clinic: The Clinic Tackling Burden HighCost Conditions with VSO |
Cleveland Clinic: TheClinic LongFormAWCF |
Sheba Medical Center: Dr. Avi Abraham Tsur |
Sheba Medical Center: Dr. Nofar Mor |
Sheba Medical Center: Dr. Talia Golan |
Sheba Medical Center: Prof. Iris Barshack |
Sheba Medical Center: Prof. Ygal Rotenstreich |
DETAILED AGENDA
May 11th
09:00-11:00 || Exhibition Networking Hours
11:00-16:00 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry
16:00-16:15 || Welcome by Conference Chairpersons
16:15-16:55 ||Francois Maisonrouge, Senior Managing Director in Evercore’s Advisory business – “Fifteen Months into the Pandemic; Four Months into the Biden Administration
What Have we Learned? What can we Expect? What Should we do?”
16:55-17:35 || Liz Barrett, President and Chief Executive Officer, UroGen Pharma – Multi Factorial Approaches to Treating Oncological Diseases
17:35-18:15 ||Prof. Ronni Gamzu, M.D., Ph.D., Chief Executive Officer, Tel Aviv Sourasky Medical Center –Post Covid Techceleration
18:15-19:00 || Latham & Watkins – The Biden Administration: A Snapshot of FDA and CMS Policy Priorities for Life Science Companies
Stuart Kurlander, Global Co-chair of the Israel Practice and Healthcare & Life Sciences Partner, Latham & Watkins
Ben Hass, Healthcare & Life Sciences Partner, Latham & Watkins
Chris Schott, Healthcare & Life Sciences Partner, Latham & Watkins
Elizabeth Richards, Healthcare & Life Sciences Partner, Latham & Watkins
John Whyte, Chief Medical Officer, WebMD
Stephen Ubl, President and CEO, Pharmaceutical Research and Manufacturers of America (PhRMA)
Sarah Pitluck, Head of Global Pricing & Reimbursement, Spark Therapeutics
19:00pm-20:00pm ||Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry
May 12th
09:00-11:00 || Exhibition Networking Hours
11:00-15:15 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry
15:15-16:00||Deloitte Panel – Next-Gen Therapies
Moderator: Arod Balissa, Deloitte Catalyst Tel-Aviv
Amit Agarwal, Managing Director, NextGen Therapies Deloitte Consulting
Arturo Araya, Chief Commercial Officer, Trakcel
Meredith Unger, Director of Marketing Cell therapy, Janssen (J&J)
Michael Mullette, VP Managing Director North America, Moderna
16:00-16:40 ||Barry Greene, Chief Executive Officer and Member of Board of Directors, Sage Therapeutics – Is There More to Discover in the Brain than on the Moon?
16:40-17:20 ||Dr. John Halamka, President of Mayo Clinic Platform, Mayo Clinic – The Digital Reconstruction of Healthcare
17:20-18:00 ||Dr. Jeremy Levin, Chairman and Chief Executive Officer, Ovid Therapeutics Inc. – Politics, Science, and Medicine do not Mix
18:00-18:45 |Hogan Lovells Panel – Medical Device and Technology Regulatory Landscape Overview and Trends Shaping the Future
Jonathan Kahan, Partner, Hogan Lovells
John Smith, Partner, Hogan Lovells
Stuart Langbein, Partner, Hogan Lovells
Randy Prebula, Partner, Hogan Lovells
18:45 -19:30 || Covington – Innovating with AI/ML: Ethical, Legal, and Regulatory Considerations
Wade Ackerman, Partner, Covington
David Wildman, Associate, Covington
19:30-20:00 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry
May 13th
09:00-11:00 || Exhibition Networking Hours
11:00-15:15 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry
15:15-16:00 || Medison Ventures Panel – Post Pandemic – A window to Digital Neuro Transformation
Thibaud Guymard, Sr. Director, Global Innovation Officer & Konectom General Manager, BHS at Biogen
Professor Gal Ifergane, Chairman of the Division of Brain Medicine at Soroka Medical Center
Dr. Tracy Dennis-Tiwary, CEO, Wise Therapeutics
Dr. Shiri Ron, Analyst, Neurology at Medison Ventures
Dr. Itsik Francis, Manager, Strategic Alliances & innovation at Medison Ventures
16:00-16:40 ||Robert C. Cohen, President, Digital, Robotics, and Enabling Technologies, Stryker Corp. – Technology Benefiting Orthopedic Device Innovation
16:40-17:00 ||Israel Innovation Authority – BioConvergence – Building Medicine of the Future:
Anya Eldan, Vice President, Israel Innovation Authority and Head of Startup Division
Prof. Rivka Carmi, M.D., ex. President of Ben Gurion University, Chairwoman of Telem National Committee of Bio Conversion
Fire Chat – Role of Bioconversion in Future therapeutic Solutions
17:00-17:20 ||Dr. Orna Berry, Entrepreneur, Scientist and Industry Executive – The AI and Data Science National Committee Initiatives for Health and Medical Fields
18:00-18:45 || Deloitte Panel – Future of Trust
Michael Bondar, Principal at Deloitte US and Future of Trust Leader
18:45-20:00 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry